APSTX Performance — Limited Duration Fund, Investor Shares
Data updated: 2026-07-27
APSTX returned +0.84% year to date and +3.42% over one year to May 2026. Annualised returns are +4.78% over 3 years and +1.87% over 5 years. The fund trailed its Intermediate Securitized Bond category average: $100 invested three years ago grew to $115, against $116 for the category, and to $103 over one year, against $106. Volatility over the past three years was 2.17% a year. In the 12 months to May 2026 the fund lost a net $6.8M, and assets reached $22.41M.
APSTX Growth of $100
What $100 invested in Limited Duration Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Securitized Bond category average over the same months.
| Period | APSTX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $103 | $106 |
| 3 years (Jun 2023 – May 2026) | $115 | $116 |
| 5 years (Jun 2021 – May 2026) | $110 | $105 |
| Since data start (Sep 2019 – May 2026) | $114 | $111 |
APSTX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +0.84% |
| 1 year | +3.42% |
| 3 years (annualised) | +4.78% |
| 5 years (annualised) | +1.87% |
APSTX Annual Returns
Calendar-year total returns of Limited Duration Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +0.84% |
| 2025 | +5.19% |
| 2024 | +4.93% |
| 2023 | +5.37% |
| 2022 | −5.79% |
| 2021 | −0.73% |
| 2020 | +3.82% |
| 2019 (Sep–Dec) | +0.20% |
APSTX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.2% | +1.0% | −0.9% | +0.3% | +0.2% | — | — | — | — | — | — | — |
| 2025 | +0.5% | +1.2% | +0.3% | +0.4% | +0.2% | +0.9% | −0.5% | +0.6% | +0.4% | +0.4% | +0.7% | 0.0% |
| 2024 | +0.6% | 0.0% | +0.6% | −0.5% | +0.8% | +0.9% | +1.2% | +1.0% | +0.9% | −0.9% | +0.7% | −0.3% |
| 2023 | +1.4% | −0.6% | +0.9% | +0.3% | −0.1% | −0.4% | +0.4% | +0.4% | −0.2% | −0.1% | +1.4% | +1.9% |
| 2022 | −0.7% | −0.7% | −1.4% | −1.1% | −0.2% | −0.6% | +0.4% | −0.7% | −1.7% | −0.7% | +1.0% | +0.5% |
| 2021 | +0.2% | −0.3% | −0.2% | +0.1% | +0.1% | −0.1% | +0.2% | 0.0% | −0.2% | −0.3% | −0.2% | −0.2% |
| 2020 | +1.1% | +1.0% | −0.6% | +0.6% | +0.3% | +0.6% | +0.4% | −0.1% | +0.1% | −0.3% | +0.4% | +0.1% |
| 2019 | — | — | — | — | — | — | — | — | −0.1% | +0.3% | +0.1% | 0.0% |
APSTX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 2.17%
- 3-year Sharpe ratio: 0.13 (vs 4.5% risk-free rate)
- Best month: +1.93% (Dec 2023)
- Worst month: −0.92% (Oct 2024)
APSTX Fund Flows
Monthly money in and out of Limited Duration Fund, from SEC Form N-PORT.
- 12-month net flow: −$6.8M
- 12-month gross sales (incl. reinvestments): $2.8M
- Sales ÷ redemptions: 0.29×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $119K | $307K | −$187K |
| Apr 2026 | $121K | $424K | −$303K |
| Mar 2026 | $155K | $210K | −$55K |
| Feb 2026 | $298K | $205K | $94K |
| Jan 2026 | $166K | $409K | −$244K |
| Dec 2025 | $251K | $3.0M | −$2.7M |
| Nov 2025 | $266K | $491K | −$225K |
| Oct 2025 | $286K | $2.7M | −$2.5M |
| Sep 2025 | $239K | $102K | $137K |
| Aug 2025 | $135K | $664K | −$529K |
| Jul 2025 | $548K | $535K | $13K |
| Jun 2025 | $194K | $562K | −$368K |
APSTX Assets Under Management
Net assets of Limited Duration Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $22.41M |
| 2026-02-28 | $23.26M |
| 2025-11-30 | $25.99M |
| 2025-08-31 | $28.36M |
| 2025-05-31 | $29.18M |
| 2025-02-28 | $30.22M |
| 2024-11-30 | $34.06M |
| 2024-08-31 | $38.16M |
| 2024-05-31 | $29.23M |
| 2024-02-29 | $31.49M |
| 2023-11-30 | $33.41M |
| 2023-08-31 | $34.03M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.